Paper7614253
Antitat gene therapy: a candidate for late-stage AIDS patients.
Lisziewicz J and 3 others. Gene Ther, 1995. Cited by 38 papers, by iCite.
Cite this record
ConductScience Library. Antitat gene therapy: a candidate for late-stage AIDS patients. Papers, record 7614253. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7614253
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Acquired Immunodeficiency Syndrome | Major topic |
| CD4-Positive T-Lymphocytes | Major topic |
| Gene Transfer Techniques | Major topic |
| Genes, tat | Major topic |
| HIV Long Terminal Repeat | Major topic |
| HIV-1 | Major topic |
| CD4 Lymphocyte Count | |
| Gene Products, tat | |
| Genetic Therapy | |
| Genetic Vectors | |
| HIV Core Protein p24 | |
| HIV Infections | |
| Humans | |
| Leukocytes, Mononuclear | |
| Lymphocyte Activation | |
| RNA, Antisense | |
| Retroviridae | |
| Virus Replication | |
| tat Gene Products, Human Immunodeficiency Virus |
Source PubMed
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 38 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 11438838 | SV40-derived vectors provide effective transgene expression and inhibition of HIV-1 using constitutive, conditional,and pol III promoters. | Gene Ther | 2001 | https://conductscience.org/library/papers/11438838 | PubMed |
| 10775598 | Identification of a key target sequence to block human immunodeficiency virus type 1 replication within the gag-pol transframe domain. | J Virol | 2000 | https://conductscience.org/library/papers/10775598 | PubMed |
| 10694813 | Inhibition of HIV-1 replication in chronically infected cell lines and peripheral blood mononuclear cells by retrovirus-mediated antitat gene transfer. | Gene Ther | 2000 | https://conductscience.org/library/papers/10694813 | PubMed |
| 10476226 | Inhibition of HIV-1 by an anti-integrase single-chain variable fragment (SFv): delivery by SV40 provides durable protection against HIV-1 and does not require selection. | Gene Ther | 1999 | https://conductscience.org/library/papers/10476226 | PubMed |
| 9457428 | Gene therapy for infectious diseases. | Clin Microbiol Rev | 1998 | https://conductscience.org/library/papers/9457428 | PubMed |
| 9219238 | Anti-HIV ribozymes. | Mol Biotechnol | 1997 | https://conductscience.org/library/papers/9219238 | PubMed |
| 9217933 | Antisense inhibition of virus infections. | Adv Pharmacol | 1997 | https://conductscience.org/library/papers/9217933 | PubMed |
| 9060627 | Transduction of CD34+ hematopoietic progenitor cells with an antitat gene protects T-cell and macrophage progeny from AIDS virus infection. | J Virol | 1997 | https://conductscience.org/library/papers/9060627 | PubMed |
| 8971011 | Intracellular expression of single-chain variable fragments to inhibit early stages of the viral life cycle by targeting human immunodeficiency virus type 1 integrase. | J Virol | 1996 | https://conductscience.org/library/papers/8971011 | PubMed |
| 8648670 | Targeting human immunodeficiency virus type 1 reverse transcriptase by intracellular expression of single-chain variable fragments to inhibit early stages of the viral life cycle. | J Virol | 1996 | https://conductscience.org/library/papers/8648670 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| TAT | 6898 | PubTator's text mining | https://conductscience.org/library/genes/6898 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7614253
GET https://conductscience.org/api/papers/v1/7614253/authors